We are live on
!
Find out more
Squarepoint Portfolio holdings
AUM
$85.1B
1-Year Est. Return
20.93%
This Fund
S&P 500
This Quarter
Est. Return
+5.06%
1 Year Est. Return
+20.93%
3 Year Est. Return
+51.38%
5 Year Est. Return
+34.63%
10 Year Est. Return
+146.23%
AUM
$8.36B
AUM Growth
+$811M
(+11%)
Cap. Flow
+$513M
Cap. Flow
% of AUM
6.13%
Top 10 Holdings %
Top 10 Hldgs %
9.6%
Holding
2,400
New
687
Increased
686
Reduced
568
Closed
456
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
VanEck Gold Miners ETF
GDX
|
+$87.3M |
| 2 |
iShares Core MSCI Emerging Markets ETF
IEMG
|
+$58.8M |
| 3 |
Wells Fargo
WFC
|
+$50M |
| 4 |
Archer Daniels Midland
ADM
|
+$46.7M |
| 5 |
Southern Company
SO
|
+$46.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard FTSE Emerging Markets ETF
VWO
|
+$79.7M |
| 2 |
Cigna
CI
|
+$69.1M |
| 3 |
iShares MSCI Taiwan ETF
EWT
|
+$46.8M |
| 4 |
Caterpillar
CAT
|
+$42.7M |
| 5 |
DXC Technology
DXC
|
+$40M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Consumer Discretionary | 18.52% |
| 2 | Technology | 13.89% |
| 3 | Financials | 12.78% |
| 4 | Industrials | 11.24% |
| 5 | Healthcare | 9.99% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EMKR
1826
DELISTED
Emcore Corp
EMKR
| $152K | ﹤0.01% |
+3,204
| New | +$156K |
|
|
FRBK
1827
DELISTED
Republic First Bancorp Inc
FRBK
| $151K | ﹤0.01% |
21,092
-3,113
| -13% | -$23.7K |
|
|
AVP
1828
DELISTED
Avon Products, Inc.
AVP
| $151K | ﹤0.01% |
68,500
-575,463
| -89% | -$1.06M |
|
1829
Rigel Pharmaceuticals
RIGL
$680M
| $150K | ﹤0.01% |
4,659
-4,323
| -48% | -$130K |
|
|
MACK
1830
DELISTED
Merrimack Pharmaceuticals, Inc.
MACK
| $150K | ﹤0.01% |
35,697
+20,092
| +129% | +$84.7K |
|
1831
Babcock & Wilcox
BW
$1.43B
| $148K | ﹤0.01% |
14,397
+10,428
| +263% | +$173K |
|
|
CLSD
1832
DELISTED
Clearside Biomedical
CLSD
| $147K | ﹤0.01% |
1,597
+780
| +95% | +$92.7K |
|
1833
Photronics
PLAB
$1.79B
| $147K | ﹤0.01% |
14,920
-66,535
| -82% | -$618K |
|
|
GCI
1834
DELISTED
Gannett Co., Inc
GCI
| $147K | ﹤0.01% |
14,726
-16,587
| -53% | -$170K |
|
|
VNET
1835
VNET Group
VNET
$2.05B
| $146K | ﹤0.01% |
+14,502
| New | +$142K |
|
|
JNCE
1836
DELISTED
Jounce Therapeutics, Inc. Common Stock
JNCE
| $146K | ﹤0.01% |
+22,509
| New | +$167K |
|
|
LOMA
1837
Loma Negra
LOMA
$1.33B
| $144K | ﹤0.01% |
+16,268
| New | +$155K |
|
|
BKS
1838
DELISTED
Barnes & Noble
BKS
| $144K | ﹤0.01% |
+24,748
| New | +$140K |
|
1839
Option Care Health
OPCH
$3.4B
| $143K | ﹤0.01% |
+11,522
| New | +$135K |
|
1840
BioXcel Therapeutics
BTAI
$26.2M
| $142K | ﹤0.01% |
+1,156
| New | +$172K |
|
1841
Ardmore Shipping
ASC
$678M
| $140K | ﹤0.01% |
+21,524
| New | +$152K |
|
1842
Cenovus Energy
CVE
$54.6B
| $138K | ﹤0.01% |
13,802
-73,040
| -84% | -$713K |
|
1843
Viavi Solutions
VIAV
$9.75B
| $137K | ﹤0.01% |
12,048
-6,686
| -36% | -$72.2K |
|
|
SOS
1844
SOS Limited
SOS
$18.2M
| $135K | ﹤0.01% |
6
| – | – |
|
|
SFE
1845
DELISTED
Safeguard Scientifics, Inc.
SFE
| $135K | ﹤0.01% |
14,470
+3,249
| +29% | +$35.3K |
|
1846
Orion Group Holdings
ORN
$514M
| $134K | ﹤0.01% |
17,755
-18,796
| -51% | -$162K |
|
1847
Frontline
FRO
$8.75B
| $131K | ﹤0.01% |
22,494
-10,933
| -33% | -$57.7K |
|
1848
Ultrapar
UGP
$6.87B
| $130K | ﹤0.01% |
+28,128
| New | +$150K |
|
|
VWTR
1849
DELISTED
Vidler Water Resouces, Inc. Common Stock
VWTR
| $128K | ﹤0.01% |
10,211
-27,064
| -73% | -$333K |
|
|
ENT
1850
DELISTED
Global Eagle Entertainment Inc.
ENT
| $128K | ﹤0.01% |
1,816
+928
| +105% | +$59.8K |
|
Similar funds
Squarepoint's Q3 2018 Portfolio in Review
As of Q3 2018, Squarepoint held 2,400 positions worth $8.36B, up 11% from $7.55B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
Squarepoint deployed $513M of net new capital in Q3 2018, opening 687 new positions and adding to 686 existing holdings. Its largest new stake was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
By sector, the portfolio is most concentrated in Consumer Discretionary at 19% of assets, up from 16% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was Cigna, an estimated $69.1M trimmed.
- Squarepoint's largest Q3 2018 buy was VanEck Gold Miners ETF: 4,374,139 shares worth $81M.
- Squarepoint added most to iShares Core MSCI Emerging Markets ETF in Q3 2018, an estimated $58.8M increase.
- Squarepoint's biggest Q3 2018 reduction was Cigna, cutting an estimated $69.1M.
- Squarepoint fully exited Vanguard FTSE Emerging Markets ETF in Q3 2018, selling an estimated $79.7M.
- Squarepoint's ten largest holdings make up 9.6% of its $8.36B portfolio in Q3 2018.
- Squarepoint opened 687 new positions and closed 456 in Q3 2018.
- Squarepoint's portfolio value rose 11% quarter-over-quarter to $8.36B.
Based on Squarepoint's 13F filing for Q3 2018, filed 14 Nov 2018.